CBCT + Therapy + MIDOMAFETAMINE for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Jul 2016: Trial started, NCT02876172
  2. 23 Aug 2016: Trial registered, NCT02876172

The trials

NCT02876172: MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD

State
Completed
Phase
Phase 1 and Phase 2
People
12 taking part
Started
3 Jul 2016
Primary completion
16 Dec 2017
Arms
MDMA-assisted therapy and CBCT
Results
Posted on the registry
  1. 3 Jul 2016: Trial started
  2. 23 Aug 2016: Trial registered
  3. 29 May 2018: Trial completed
  4. 19 Jul 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.